Moderna, Inc. (NASDAQ:MRNA) | WebDisclosure

Basculer en Français

8235	Companies
111177	Keywords
52887	Articles
61025	Press releases

Home
Companies
Moderna, Inc.

PRESS RELEASE

published on 08/14/2024 at 13:00, 2 months 26 days ago

Moderna and Coursera Launch Free Course on mRNA Technology
Moderna and Coursera partner to offer free course 'mRNAs as Medicines' to enhance understanding of mRNA technology and its applications in medicine, supporting STEM education globally

MRNA Technology Moderna STEM Education Coursera MRNAs As Medicines
BRIEF

published on 08/01/2024 at 12:35, 3 months 8 days ago

Moderna publie ses résultats financiers et ses mises à jour pour le deuxième trimestre 2024

Résultats Financiers Moderne T2 2024 Vaccin ARNm
BRIEF

published on 08/01/2024 at 12:35, 3 months 8 days ago

Moderna Reports Second Quarter 2024 Financial Results and Business Updates

Financial Results Q2 2024 Moderna Vaccine MRNA
PRESS RELEASE

published on 08/01/2024 at 12:30, 3 months 8 days ago

Moderna Reports Second Quarter 2024 Financial Results and Provides Business Updates
Moderna, Inc. reports Q2 revenues of $241 million, GAAP net loss of $1.3 billion. Updates 2024 financial framework and expects product sales of $3.0-$3.5 billion. Announces key developments in vaccines and financial results

Financial Framework Moderna Business Updates Q2 Revenues Vaccine Approvals
BRIEF

published on 07/23/2024 at 13:05, 3 months 17 days ago

David Rubenstein rejoint le conseil d'administration de Moderna

Biotechnologie David Rubenstein Robert Langer Stephen Berenson Tableau Moderna
BRIEF

published on 07/23/2024 at 13:05, 3 months 17 days ago

David Rubenstein Joins Moderna's Board of Directors

Biotechnology David Rubenstein Moderna Board Robert Langer Stephen Berenson
PRESS RELEASE

published on 07/23/2024 at 13:00, 3 months 17 days ago

David Rubenstein Joins Moderna's Board of Directors
David M. Rubenstein joins Moderna's Board of Directors, replacing retiring directors Robert Langer and Stephen Berenson. Rubenstein brings vast investor and policy expertise from The Carlyle Group

Board Of Directors Moderna David M. Rubenstein The Carlyle Group Global Policy Expertise
BRIEF

published on 07/10/2024 at 13:05, 3 months 30 days ago

Moderna publiera ses résultats financiers du deuxième trimestre 2024 le jeudi 1er août 2024

Résultats Financiers Webdiffusion Conférence Téléphonique Moderne T2 2024
BRIEF

published on 07/10/2024 at 13:05, 3 months 30 days ago

Moderna to Report Second Quarter 2024 Financial Results on Thursday, August 1, 2024

Financial Results Conference Call Webcast Q2 2024 Moderna
PRESS RELEASE

published on 07/10/2024 at 13:00, 3 months 30 days ago

Moderna to Report Second Quarter 2024 Financial Results on Thursday, August 1, 2024
Moderna, Inc. will host a live conference call and webcast on August 1, 2024, reporting its second quarter financial results and giving a corporate update. Moderna leads in mRNA medicine, developing treatments and vaccines for various diseases

Financial Results Moderna Inc. MRNA Medicine Vaccines Live Conference Call

Accesswire

Published on 11/10/2024 at 02:00, 4 hours 11 minutes ago

Spey Resources Corp. enters into Share Exchange Agreement with Antimony Assets and announces Name Change
Published on 11/09/2024 at 16:30, 13 hours 41 minutes ago

New to the Street Premieres Episode 611 on Bloomberg Television Tonight at 6:30 PM EST, Featuring Zapp Electric Vehicles, OriginClea and PillSafe
Published on 11/09/2024 at 04:00, 1 day 2 hours ago

Freedom Holding Corp. Reports Second Quarter Fiscal Year 2025 Financial Results
Published on 11/08/2024 at 23:05, 1 day 7 hours ago

Murchison Minerals Announces Non-Brokered Private Placement
Published on 11/08/2024 at 22:30, 1 day 7 hours ago

Justera Health Announces RSU Grant

View all ACCESSWIRE

EQS Group

Published on 11/08/2024 at 18:35, 1 day 11 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/08/2024 at 18:20, 1 day 11 hours ago

ENCAVIS achieves results in the first three quarters of 2024 below the figures for the same period of the previous year due to unforeseeable events and adjusts guidance for the current financial year
Published on 11/08/2024 at 18:15, 1 day 11 hours ago

EQS-Adhoc: ENCAVIS AG
Published on 11/08/2024 at 18:02, 1 day 12 hours ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/08/2024 at 18:00, 1 day 12 hours ago

2CRSi SA: Provision of the Financial Report

Les Echos

Published on 11/08/2024 at 18:00, 1 day 12 hours ago

Covivio - Informations relatives au nombre total de droits de vote et d’actions composant le capital social
Published on 11/08/2024 at 18:00, 1 day 12 hours ago

Covivio - Information on total number of voting rights and share capital
Published on 11/08/2024 at 17:52, 1 day 12 hours ago

Total number of voting rights and shares making up the share capital at October 31, 2024
Published on 11/08/2024 at 17:52, 1 day 12 hours ago

Capital et droits de vote au 31 octobre 2024
Published on 11/08/2024 at 17:45, 1 day 12 hours ago

CHARGEURS - Voting rights monthly statement as of October 31st, 2024

View all LES ECHOS COMFI WIRE